Top in endocrinology: Bloodless glucose monitoring, sexual dysfunction in menopause

In a recent article, experts described noninvasive and minimally invasive products for bloodless glucose monitoring and barriers to their widespread use, including concerns about accuracy. It was the top story in endocrinology last week.

A review of new data on sexual dysfunction during menopause was another top story. Researchers identified ethnic and geographic disparities in sexual dysfunction among menopausal women. They said more research is needed to better understand the associations of ethnicity, locations and symptom prevalence.

Read these and more top stories in endocrinology below:

Noninvasive glucose monitoring may change future of diabetes management

More than 60 noninvasive and minimally invasive bloodless glucose monitoring products are available or in development, and the devices may become important digital tools for people with diabetes, according to a review article. Read more.

Sexual dysfunction risk differs by ethnicity, geography for menopausal women

A group of Hispanic women from Texas reported more sexual dysfunction symptoms compared with non-Hispanic women, and menopausal women in Texas noted fewer sexual dysfunction symptoms than those from Arizona, according to study data. Read more.

HbA1c variability increases mortality risk in diabetes

Adults with diabetes in Israel had an increased mortality risk with higher variability in HbA1c levels over a period of 5 years, according to a study published in Diabetes/Metabolism Research and Reviews. Read more.

Access to obesity medications boosts weight loss in employer-based program

Adults with obesity participating in a real-world, employer-based weight-management program were significantly more likely to achieve clinically meaningful weight loss when adding pharmacotherapy to shared monthly visits, data show. Read more.

Evidence lacking on effect of false-positive infant congenital hypothyroidism tests

Few studies have evaluated infant and parental outcomes of false-positive results from newborn screening of congenital hypothyroidism, and most studies are low or moderate quality, according to a systematic review. Read more.